A novel series of 1,2,4-triazolyl 5-azaspiro[2.4]heptanes with high affinity and selectivity at the dopamine (DA) D3 receptor (D3R) is described. Some of these compounds also have high selectivity over the hERG channel and were characterized with respect to their pharmacokinetic properties both in vitro and in vivo during lead identification and early lead optimization phases. A few derivatives with overall favorable developability characteristics were selected for further late lead optimization studies.

1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists / Micheli, Fabrizio; Bacchi, Alessia; Braggio, Simone; Castelletti, Laura; Cavallini, Palmina; Cavanni, Paolo; Cremonesi, Susanna; Dal Cin, Michele; Feriani, Aldo; Gehanne, Sylvie; Kajbaf, Mahmud; Marchio', Luciano; Nola, Selena; Oliosi, Beatrice; Pellacani, Annalisa; Perdonà, Elisabetta; Sava, Anna; Semeraro, Teresa; Tarsi, Luca; Tomelleri, Silvia; Wong, Andrea; Visentini, Filippo; Zonzini, Laura; Heidbreder, Christian. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 59:18(2016), pp. 8549-8576. [10.1021/acs.jmedchem.6b00972]

1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists

MICHELI, FABRIZIO;BACCHI, Alessia;MARCHIO', Luciano;
2016

Abstract

A novel series of 1,2,4-triazolyl 5-azaspiro[2.4]heptanes with high affinity and selectivity at the dopamine (DA) D3 receptor (D3R) is described. Some of these compounds also have high selectivity over the hERG channel and were characterized with respect to their pharmacokinetic properties both in vitro and in vivo during lead identification and early lead optimization phases. A few derivatives with overall favorable developability characteristics were selected for further late lead optimization studies.
1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists / Micheli, Fabrizio; Bacchi, Alessia; Braggio, Simone; Castelletti, Laura; Cavallini, Palmina; Cavanni, Paolo; Cremonesi, Susanna; Dal Cin, Michele; Feriani, Aldo; Gehanne, Sylvie; Kajbaf, Mahmud; Marchio', Luciano; Nola, Selena; Oliosi, Beatrice; Pellacani, Annalisa; Perdonà, Elisabetta; Sava, Anna; Semeraro, Teresa; Tarsi, Luca; Tomelleri, Silvia; Wong, Andrea; Visentini, Filippo; Zonzini, Laura; Heidbreder, Christian. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 59:18(2016), pp. 8549-8576. [10.1021/acs.jmedchem.6b00972]
File in questo prodotto:
File Dimensione Formato  
JMedChem_FMicheli_spiro_draft8_Indivior_AB-2016.pdf

accesso aperto

Descrizione: versione pre-referaggio
Tipologia: Documento in Pre-print
Licenza: Creative commons
Dimensione 3.01 MB
Formato Adobe PDF
3.01 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2817890
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 12
social impact